Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400091706Phase 4Recruiting
Phase 4, randomised trial in osteoarthritis (OA) comparing Ketoprofen gel cataplasm monotherapy, Celecoxib monotherapy and Ketoprofen gel cataplasm + celecoxib combination (3 arms). Primary endpoint: Effective rate. Started Nov 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400091706.